Cleared Abbreviated

K110530 - ABX PENTRA CREATININE 120 CP (FDA 510(k) Clearance)

Also includes:
ABX PENTRA MULTICAL ABX PENTRA N CONTROL ABX PENTRA P CONTROL ABX PENTRA URINE CONTROL
Apr 2012
Decision
431d
Days
Class 2
Risk

K110530 is an FDA 510(k) clearance for the ABX PENTRA CREATININE 120 CP. This device is classified as a Alkaline Picrate, Colorimetry, Creatinine (Class II - Special Controls, product code CGX).

Submitted by HORIBA ABX SAS (Montpellier, FR). The FDA issued a Cleared decision on April 30, 2012, 431 days after receiving the submission on February 24, 2011.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1225.

Submission Details

510(k) Number K110530 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2011
Decision Date April 30, 2012
Days to Decision 431 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CGX - Alkaline Picrate, Colorimetry, Creatinine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1225